AZD3427
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD3427, covering 2025-09-24 to 2025-09-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 [Phase 2]